林 志慶

Medicine & Life Sciences

1. Renal Dialysis 100%
2. Arteriovenous Fistula 42%
3. Peritoneal Dialysis 27%
4. Blood Vessels 22%
5. Dialysis 22%
6. Kidney 22%
7. Diabetic Nephropathies 21%
8. Taiwan 21%
9. Chronic Renal Insufficiency 20%
10. continuous erythropoietin receptor activator 18%
11. Chronic Kidney Failure 17%
12. Vascular Patency 16%
13. Heme Oxygenase-1 15%
14. N,N-dimethylarginine 14%
15. Genotype 13%
16. Continuous Ambulatory Peritoneal Dialysis 11%
17. Creatinine 10%
18. Cohort Studies 10%
19. Thrombosis 10%
20. Therapeutics 9%
21. Transplants 9%
22. Canagliflozin 9%
23. Acrolein 8%
24. Glomerulonephritis 8%
25. Acute Kidney Injury 7%
26. Nodular Goiter 7%
27. Serum 7%
28. Angiotensin Receptor Antagonists 7%
29. Mortality 7%
30. Randomized Controlled Trials 7%
31. Stroke 7%
32. Pneumocystis carinii 7%
33. Dipeptidyl-Peptidase IV Inhibitors 7%
34. Yoga 7%
35. Epidemiology 7%
36. Southeastern Asia 7%
37. Hematocrit 7%
38. Ankle Brachial Index 7%
39. Coronavirus 7%
40. Pneumocystis Pneumonia 7%
41. Thyroid Gland 7%
42. Podocytes 6%
43. Far East 6%
44. Hypoglycemia 6%
45. Angiotensin-Converting Enzyme Inhibitors 6%
46. Maintenance 6%
47. Blood Pressure 6%
48. Proteinuria 6%
49. Inflammation 6%